Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I

被引:31
作者
Superko, HR
McGovern, ME
Raul, E
Garrett, B
机构
[1] Cholesterol Genet & Heart Dis Inst, Portola Valley, CA 94028 USA
[2] Piedmont Hosp, Fuqua Heart Ctr, Fuqua Ctr Prevent, Atlanta, GA USA
[3] Berkeley Heartlab, Burlingame, CA USA
[4] KOS Pharmaceut, Miami, FL USA
关键词
D O I
10.1016/j.amjcard.2004.05.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We tested the hypothesis that treatment with nicotinic acid results in a differential blood lipid response in subjects classified as having a low-density lipoprotein (LDL) pattern A or B. One hundred eighty hypercholesterolemic subjects were randomized to placebo (n = 61), immediate-release niacin (3,000 mg/day, n = 59), or extended-release niacin (1,500 mg/day, n = 60) for 14 weeks. Lipids and lipoprotein cholesterol were determined with enzymatic methods. LDL subclass distribution was determined with 2% to 16% polyacrylamide gradient gel electrophoresis. Extended- and immediate-release niacin had significant effects on the decrease of triglycerides, total cholesterol, LDL cholesterol, apoprotein B, lipoprotein(a), and apoprotein A-1 and significantly increased high-density lipoprotein 'cholesterol. The 2 nicotinic acid compounds and doses significantly increased mean LDL peak particle diameter and percent distribution in large LDL I and IIa, with a significant decrease in small LDL IIIa, IIIb, and IVb. In patients with LDL pattern B compared with those with pattern A, extended-release niacin (1,500 mg/day) increased LDL peak particle diameter significantly more and decreased the percent distributions of small LDL IIIa, LDL IIIb, and LDL IVa significantly more. With 3,000 mg/day, immediate-release nicotinic acid in patients with LDL pattern B exhibited a significantly greater increase in LDL peak particle diameter and large LDL IIa and lib and significantly greater decreases in small LDL Ilia, IIIb, and IVa compared with patients with pattern A. These differences in response between patients with LDL pattern A and those with pattern B were not reflected by changes in the standard lipid profile, including apoproteins A-1 and B. Nicotinic acid has a significantly different effect on lipids and lipoprotein subclass distribution in subjects classified as having LDL subclass pattern A or B. Nicotinic acid has a significantly greater effect on the decrease of small LDL subclass distribution and increase in LDL peak particle diameter in pattern B versus pattern A. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:588 / 594
页数:7
相关论文
共 21 条
[1]  
[Anonymous], 1992, Current Opinion in Lipidology
[2]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[3]   15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].
CANNER, PL ;
BERGE, KG ;
WENGER, NK ;
STAMLER, J ;
FRIEDMAN, L ;
PRINEAS, RJ ;
FRIEDEWALD, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255
[4]   LOW-DENSITY-LIPOPROTEIN SUBCLASS PATTERNS AND LIPOPROTEIN RESPONSE TO A REDUCED-FAT DIET IN MEN [J].
DREON, DM ;
FERNSTROM, HA ;
MILLER, B ;
KRAUSS, RM .
FASEB JOURNAL, 1994, 8 (01) :121-126
[5]  
FELDMAN DS, 1994, STATVIEW 2
[6]   Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia [J].
Goldberg, A ;
Alagona, P ;
Capuzzi, DM ;
Guyton, J ;
Morgan, JM ;
Rodgers, J ;
Sachson, R ;
Samuel, P .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (09) :1100-1105
[7]   Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia [J].
Knopp, RH ;
Alagona, P ;
Davidson, M ;
Goldberg, AC ;
Kafonek, SD ;
Kashyap, M ;
Sprecher, D ;
Superko, HR ;
Jenkins, S ;
Marcovina, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (09) :1097-1104
[8]   Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the stanford coronary risk intervention project [J].
Miller, BD ;
Alderman, EL ;
Haskell, WL ;
Fair, JM ;
Krauss, RM .
CIRCULATION, 1996, 94 (09) :2146-2153
[9]  
MILLER BD, 1993, CIRCULATION, V88, P363
[10]   THE CENTERS FOR DISEASE CONTROL-NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE LIPID STANDARDIZATION PROGRAM - AN APPROACH TO ACCURATE AND PRECISE LIPID MEASUREMENTS [J].
MYERS, GL ;
COOPER, GR ;
WINN, CL ;
SMITH, SJ .
CLINICS IN LABORATORY MEDICINE, 1989, 9 (01) :105-135